Waxaan u hambalyeynayaa in Bigfish Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) la guddoonsiiyay shahaadada CE ee Yurub.

Waqtigan xaadirka ah, cudurku si isdaba joog ah ayuu isu beddelay fayraskuna si joogto ah ayuu isu beddelay. Sida laga soo xigtay tirakoobyada la soo saaray Noofambar 10, tirada kiisaska COVID-19 ee adduunka oo dhan ayaa kor u kacday in ka badan 540,000, tirada guud ee kiisaska la xaqiijiyayna waxay dhaaftay 250 milyan. COVID-19 wuxuu si aan horay loo arag u saameeyaa caafimaadka iyo dhaqaalaha dadka adduunka oo dhan. Ka gudubka cudurka faafa waqti hore iyo soo celinta kobaca dhaqaalaha ayaa ah mudnaanta koowaad ee bulshada caalamka. Marka laga eego ka hortagga cudurka faafa ee dibadda, waxaa jira baahi suuqeed oo ballaaran oo loogu talagalay alaabada antigen-ka ee COVID-19.

Dhawaan, Tijaabada Degdegga ah ee Ka-hortagga Fayraska Cusub (SARS-CoV-2) ee Ka-hortagga Fayraska (Colloidal Gold) oo ay samaysay Bigfish ayaa la siiyay shahaadada CE ee Midowga Yurub. Ka dib marka la helo shahaadada CE, badeecada waxaa laga iibin karaa wadamada Midowga Yurub iyo wadamada aqoonsan shahaadada CE, taasoo sii kobcinaysa khadka wax soo saarka shirkadda.

Coronavirus-ka Cusub (SARS-CoV-2) Baaritaanka Degdegga ah ee Ka-hortagga Jeermiska (Dahabka Colloidal) ee Bigfish waa mid si fudud loo shaqayn karo iyada oo aan la isticmaalin qalab, waana mid si dhakhso ah loo ogaan karo. Natiijooyinka waxaa la heli karaa 15 daqiiqo gudahood. Waxay sidoo kale aqoonsan kartaa caabuq ba'an ama hore.

Iyadoo la wajahayo caabuqa cusub ee coronavirus, Bigfish waxay diiradda saari doontaa teknoolojiyada asaasiga ah oo leh qaab shaqo oo adag oo macquul ah. Waxaan bixin doonnaa badeecooyin iyo adeegyo aad u fiican si aan gacan uga geysanno ka hortagga iyo xakamaynta cudurrada faafa ee adduunka oo dhan.